Note: Ingredients listed on restricted chemical lists
EC/CAS
215-137-3/1305-62-0
Name of the chemical
Calcium dihydroxide
Concentration
>=21.0-<=31.0
EC/CAS
231-955-3/7782-42-5
Name of the chemical
Graphite
Concentration
>=8.0-<=12.0%
EC/CAS
215-263-9/1317-33-5
Name of the chemical
molybdenum disulphide
Concentration
>=6.0-<10.0%
General Information
Version
6.0
Revision date
2024-09-10
Product name
MOLYKOTE G-N Plus Paste
1.2.1 Relevant identified uses
Lubricants and lubricant additives
Manufacturer Name
DuPont Specialty Products GmbH & Co. KG
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
DuPont Specialty Products GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion-EU@dupont.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
DANGER
Hazard statements
H318 Causes serious eye damage.
Precautionary statements
P280 Wear eye protection/ face protection. P305 + P351 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, + P338 + if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ P310 doctor. Supplemental informationThe following percentage of the mixture consists of ingredient(s) with unknown acute dermal toxicity: 13 % The following percentage of the mixture consists of ingredient(s) with unknown acute inhalation toxicity: 4 %
Contains
Calcium hydroxide
2.3 Other hazards
Endocrine disrupting properties (human health): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine disrupting properties (environment): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008: Serious eye damage - Category 1 - H318 ® ™ Trademark of affiliates of DuPont de Nemours, Inc. For the full text of the H-Statements mentioned in this Section, see Section 16.
